The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Jazz Pharmaceuticals plc shares valued at $332,605 were sold by Iannone Robert on Mar 10 ’25. At $138.41 per share, Iannone Robert sold 2,403 shares. The insider’s holdings dropped to 79,621 shares worth approximately $10.06 million following the completion of this transaction.
Also, Carr Patricia sold 1,140 shares, netting a total of over 157,103 in proceeds. Following the sale of shares at $137.81 each, the insider now holds 7,012 shares.
Before that, Iannone Robert had added 1,767 shares to its account. In a trade valued at $256,215, the Officer bought Jazz Pharmaceuticals plc shares for $145.00 each.
As published in a research note from UBS on March 07, 2025, Jazz Pharmaceuticals plc [JAZZ] has been rated up from a Neutral to a Buy and the price target has been revised to $179 from $145. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 13, 2025, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for JAZZ. Earlier on December 12, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for JAZZ stock which previously was a “an Equal-weight”.
Analyzing JAZZ Stock Performance
During the last five days, there has been a drop of approximately -10.08%. Over the course of the year, Jazz Pharmaceuticals plc shares have jumped approximately 2.64%. Shares of the company reached a 52-week high of $148.06 on 02/26/25 and a 52-week low of $118.72 on 01/10/25. A 50-day SMA is recorded $132.08, while a 200-day SMA reached $118.37.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 124.54, which, if violated, would cause prices to drop to 122.67. In the upper region, resistance lies at 129.52. The next price resistance is at 132.63. RSI (Relative Strength Index) is 36.08 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.17, which suggests the price will decrease in the coming days. Percent R is at 96.38%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
